Reduced Risk for Mpox After Receipt of 1 or 2 Doses of JYNNEOS Vaccine Compared with Risk Among Unvaccinated Persons — 43 U.S. Jurisdictions, July 31–October 1, 2022
Amanda B. Payne, Logan C. Ray, Matthew M. Cole, Michelle Canning, Kennedy Houck, Hazel J. Shah, Jennifer L. Farrar, Nathaniel M. Lewis, Amy Fothergill, Elizabeth B. White, Leora R. Feldstein, Lauren E. Roper, Florence Lee, Jennifer L. Kriss, Emily Sims, Ian H. Spicknall, Yoshinori Nakazawa, Adi V. Gundlapalli, Tom T. Shimabukuro, Adam L. Cohen, Margaret A. Honein, Jonathan Mermin, Daniel C. Payne
Abstract
(5).
Topics & Concepts
MedicineIncidence (geometry)VaccinationPopulationOutbreakDemographyPediatricsEnvironmental healthImmunologyVirologyOpticsPhysicsSociologyPoxvirus research and outbreaksBacillus and Francisella bacterial researchHerpesvirus Infections and Treatments